Pilar Garrido is Associate Professor of Medical Oncology at Universidad de Alcalá and serves as Head of the Thoracic Tumours Section in the Medical Oncology Department at the University Hospital Ramón y Cajal in Madrid, Spain.
Co-director of the Cancer and Chronic Disease Research Group at Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), her main areas of research and clinical interest are thoracic tumours, in particular multimodality management, predictive biomarkers, immunotherapy and new anticancer agents in lung cancer. Dr. Garrido is in charge of teaching and patients care, and is also actively involved in a number of phase I-III lung cancer clinical trials. An active member of Ciberonc, a Spanish Ministry of Health Network of clinical and translational research, she is building a translational program in collaboration with other clinical and experimental biology Spanish cancer groups. Author of several peer-reviewed manuscripts and book chapters, she serves on the editorial board of different journals, including Annals of Oncology, and has presented her work nationally and internationally.
Former president of the Spanish Medical Oncology Society, she currently participates on a variety of national scientific committees including the Spanish National Cancer Strategy Committee and the Minister of Health advisory council.
She is a member of the ESMO Council and Chair of the Women For Oncology Committee, and is also involved as member of the ESMO Fellowship and Award Committee, Press & Media Affairs Committee, IASLC Bylaws Committee and ESMO Faculty for lung and other thoracic tumours.
EM-40026 - Date of preparation: August 2020